Furthermore, there exist needs to integrate our multigene panels with the current knowledge (Weiss score, Ki67 index, C1A-C1B, CoC, CIMP, and COMBI score) to cover different aspects relevant to ACC progression and prognosis to better serve the clinical needs. This evidence concerns the gene MKI67 and adrenal cortex carcinoma.